mylife Diabetes Care Belgium
0681.676.705 · rovalta.com · 27/09/2026
ACTIVE
mylife Diabetes Care Belgium
Financial year 2025 · Closed on 31/03/2025
Net result39,6 k €+526,3 %over 1 year
Gross margin329 k €+27,7 %over 1 year
Equity351,4 k €+12,7 %over 1 year
Workforce2,0 ETP+17,6 %over 1 year
Overview
Identity
Source · BCE/KBOmylife Diabetes Care Belgium is a Private limited company incorporated in 2017. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Anderlecht. It employs on average 2,0 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0681.676.705
- Incorporation
- 22/09/2017
- Legal form
- Private limited company
- Registered office
- Allée de la Recherche 12
1070 Anderlecht · BruxellesSee on map - Contributed capital
- 300 000,00 €
- Latest accounts
- 31/03/2025
- Average workforce
- 2,0 ETP
Activities (NACE)
Joint committees (2)
- 14901
- 218
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 8 filingsTrend over 6 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 329 k € | +27.7% | 257,5 k € | +19.1% | 216,3 k € | +14.7% | 188,5 k € | -2.7% | 193,7 k € |
| EBITDA | 68,9 k € | +224% | 21,3 k € | +53.6% | 13,9 k € | +101% | 6,9 k € | -2.3% | 7,1 k € |
| Operating result | 67,8 k € | +235% | 20,2 k € | +45.9% | 13,9 k € | +101% | 6,9 k € | +6.3% | 6,5 k € |
| Net result | 39,6 k € | +526% | 6,3 k € | +88.7% | 3,4 k € | +370% | -1,2 k € | -75.7% | -707,5 € |
| Balance sheet | |||||||||
| Equity | 351,4 k € | +12.7% | 311,8 k € | +2.1% | 305,4 k € | +1.1% | 302,1 k € | -0.4% | 303,3 k € |
| Total assets | 827,1 k € | +16.4% | 710,4 k € | +44.3% | 492,4 k € | +2.3% | 481,6 k € | -4.9% | 506,3 k € |
| Cash | 299,8 k € | +264% | 82,4 k € | +153% | 32,6 k € | +15.4% | 28,3 k € | -0.6% | 28,4 k € |
| Debts | 469,4 k € | +19.8% | 391,8 k € | +111% | 185,6 k € | +4.1% | 178,3 k € | -11.8% | 202 k € |
| Other | |||||||||
| Workforce | 2,0 ETP | +17.6% | 1,7 ETP | 0.0% | 1,7 ETP | -15.0% | 2,0 ETP | 0.0% | 2,0 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/03/20251 active · 2 ended
Active mandates
| Director | Function | Mandate |
|---|---|---|
Johan Lundstörm | Director | since 29/07/2025 |
Ended mandates
| Director | Function | Mandate |
|---|---|---|
David Herkelman | Director | since 22/09/2017 |
David Herkelman | Manager | since 22/09/2017 |
Other companies at this address
Allée de la Recherche 12 1070 Anderlecht| Company | CBE no. |
|---|---|
50°NORTH VENTURES● Liquidation | 0507.740.263 |
ABATON● Active | 1009.214.625 |
ADI NAT PROJECT● Active | 1007.049.149 |
AKAEGIS● Active | 0794.737.925 |
Alfa-Zet Systems● Active | 0459.019.638 |
Align Technology Belgium● Active | 1017.472.689 |
ARVOS● Active | 0711.896.658 |
ASPL● Active | 0731.937.749 |
BATICOOL● Active | 0443.943.759 |
BELGIOPHAR● Active | 0760.405.269 |
BH & PARTNERS● Active | 0885.975.927 |
Bizitip● Active | 0769.754.881 |
Brussels Medical Device Center● Active | 0663.935.801 |
CAPTRACK● Active | 0452.671.482 |
CAROLL BELGIQUE● Active | 0808.605.856 |
| 0476.748.565 | |
CLEAN UP HOME● Active | 0819.633.964 |
CYRILLUS BENELUX● Active | 0442.112.340 |
| 0448.319.845 | |
DENTOZO-ACADEMY● Active | 0798.717.202 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/04/2024 | 01/04/2023 | 01/04/2022 | 01/04/2021 | 01/04/2020 | 01/04/2019 |
| Closing of the financial year | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 | 31/03/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 05/11/2025 | 27/09/2024 | 05/09/2023 | 30/09/2022 | 02/11/2021 | 04/02/2021 |
| General meeting | 01/09/2025 | 02/09/2024 | 01/09/2023 | 02/08/2022 | 16/09/2021 | 09/09/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 8 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/03/2025 | 01/09/2025 | 05/11/2025 | Dutch | |
| Abridged model | 31/03/2024 | 02/09/2024 | 27/09/2024 | Dutch | |
| Abridged model | 31/03/2023 | 01/09/2023 | 05/09/2023 | Dutch | |
| Abridged model | 31/03/2022 | 02/08/2022 | 30/09/2022 | Dutch | |
| Abridged model | 31/03/2021 | 16/09/2021 | 02/11/2021 | Dutch | |
| Abridged model | 31/03/2020 | 09/09/2020 | 04/02/2021 | Dutch | |
| Abridged model | 31/03/2020 | 07/09/2020 | 20/10/2020 | Dutch | |
| Abridged model | 31/03/2019 | 30/09/2019 | 29/10/2019 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/03/20251 active · 2 ended
Active mandates
| Director | Function | Mandate |
|---|---|---|
Johan Lundstörm | Director | since 29/07/2025 |
Ended mandates
| Director | Function | Mandate |
|---|---|---|
David Herkelman | Director | since 22/09/2017 |
David Herkelman | Manager | since 22/09/2017 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other26/05/2026BENAMING
- Mandates27/08/2025ONTSLAGEN - BENOEMINGEN
- Capital / shares30/01/2025KAPITAAL - AANDELEN
- Mandates22/10/2024ONTSLAGEN - BENOEMINGEN
- Mandates02/01/2023STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING
- Mandates21/03/2022ONTSLAGEN - BENOEMINGEN
- Other26/09/2017RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202539,6 k €↑
- 2024Annual accounts 20246,3 k €↑
- 2023Annual accounts 20233,4 k €↑
- 2022Annual accounts 2022-1,2 k €↓
- 2021Annual accounts 2021-707,5 €↓
- 2020Annual accounts 202013,1 k €
- 22/09/2017IncorporationPrivate limited company
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| mylife Diabetes Care BelgiumCurrent | CBE, tracked since 27/09/2026 | CBE |
| Ypsomed | accounts 2022 → 2025 | Accounts 2025 · 2025-00563616 |
Annual accounts date a value by the financial year it appears in. The CBE dates a change to the day, but its history has only been kept since 27/09/2026.